Growth inhibition of human pancreatic cancer cells by sphingosylphosphorylcholine and influence of culture conditions

Cellular and Molecular Life Sciences

Volumn 53, Issue 5, 1997, Pages 435-441

  Yamada, T ^a   Okajima, F ^a   Ohwada, S ^a   Kondo, Y ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Growth modulation; Pancreatic cancer; Sphingolipids

Indexed keywords

ANTINEOPLASTIC AGENT; CERAMIDE DERIVATIVE; INSULIN; MITOGENIC AGENT; SPHINGOLIPID; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE DERIVATIVE; SPHINGOSYLPHOSPHORYLCHOLINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL STRAIN 3T3; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS CANCER;

3T3 CELLS; ANIMALS; CATTLE; CELL CULTURE TECHNIQUES; CELL CYCLE; CELL DIVISION; CERAMIDES; DNA; HUMANS; LYSOPHOSPHOLIPIDS; MICE; NUCLEIC ACID SYNTHESIS INHIBITORS; PANCREATIC NEOPLASMS; PHOSPHORYLCHOLINE; SERUM ALBUMIN; SPHINGOSINE; TUMOR CELLS, CULTURED;

AGOUTI PACA; ANIMALIA; BOVINAE;

EID: 0030773229     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000180050052     Document Type: Article

References (26)

1. Aoki K., Yoshida T., Sugimura T. and Terada M. (1995) Liposome-mediated in vivo gene transfer of antisense K-ras construct inhibits pancreatic tumor dissemination in the murine peritoneal cavity. Cancer Res. 55: 3810-3816
2. Ettinghausen S. E., Schwartzentruber D. J. and Sindelar W. F. (1995) Evolving strategies tor the treatment of adenocarcinoma of the pancreas. A review. J. Clin. Gastroenterol. 21: 48-60
3. Warshaw A. L. and Fernandez del Castillo C. (1992) Pancreatic carcinoma. New Engl. J. Med. 326: 455-465
4. Watanabe T., Fuchimoto S., Iwagaki H., Nonaka Y., Nezu M., Nishina T. et al. (1993) Anti-proliferative effect of combined tumour necrosis factor-alpha and interferon-alpha on human pancreatic cancer in vitro and in vivo. Anticancer Res. 13: 1501-1505
5. Matsuno S., Hisano H., Kobari M. and Akaishi S. (1990) Growth-inhibitory effect of combination chemotherapy for human pancreatic cancer cell lines. Cancer 66: 2369-2374
6. Imai S., Nio Y., Shiraishi T., Manabe T. and Tobe T. (1991) In vivo inhibitory effect of anticancer agents on human pancreatic cancer xenografts transplanted in nude mice. Anti-cancer Res. 11: 657-664
7. Ledeen R. W. (1984) Biology of gangliosides: neuritogenic and neuronotrophic properties. J. Neurosci. Res. 12: 147-159
8. Hakomori S. (1985) Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 45: 2405-2414
9. Igarashi Y., Hakomori S., Toyokuni T., Dean B., Fujita S., Sugimoto M. et al. (1989) Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities. Biochemistry 28: 6796-6800
10. Strasberg P. M. and Callahan J. W. (1988) Psychosine and sphingosylphosphorylcholine bind to mitochondrial membranes and disrupt their function. In: Lipid storage disorders, pp. 601-606, Salvarye R., Douste B. L., Gatt S. (eds). Plenum Press, New York and London
11. Desai N. N., Carlson R. O., Mattie M. E., Olivera A., Buckley N. E., Seki T. et al. (1993) Signaling pathways for sphingosylphosphorylcholine-mediated mitogenesis in Swiss 3T3 fibroblasts. J. Cell Biol. 121: 1385-1395
12. Desai N. N. and Spiegel S. (1991) Sphingosylphosphorylcholinc is a remarkably potent mitogen for a variety of cell lines. Biochem. Biophys. Res. Commun. 181: 361-366
13. Sun L., Xu L., Henry F. A., Spiegel S. and Nielsen T. B. (1996) A new wound healing agent-sphingosylphosphorylcholine. J. Invest. Dermatol. 106: 232-237
14. Xu Y., Fang X. J., Casey G. and Mills G. B. (1995) Lysophospholipids activate ovarian and breast cancer cells. Biochem. J. 309: 933-940
15. Zhang H., Desai N. N., Olivera A., Seki T., Brooker G. and Spiegel S. (1991) Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 114: 155-167
16. Gomez Munoz A., Waggoner D. W., O'Brien L. and Brindley D. N. (1995) Interaction of ceramides, sphingosine, and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity. J. Biol. Chem. 270: 26318-26325
17. Pushkareva M., Chao R., Bielawska A., Merrill A. H. Jr., Crane H. M., Lagu B. et al. (1995) Stereoselectivity of induction of the retinoblastoma gene product (pRb) dephosphorylation by D-erythrosphingosine supports a role for pRb in growth suppression by sphingosine. Biochemistry 34: 1885-1892
18. Van Veldhoven P. P., Foglesong R. J. and Bell R. M. (1989) A facile enzymatic synthesis of sphingosine-1-phosphate and dihydrosphingosine-1-phosphate. J. Lipid Res. 30: 611-616
19. Spiegel S. and Panagiotopoulos C. (1988) Mitogenesis of 3T3 fibroblasts induced by endogenous ganglioside is not mediated by cAMP, protein kinase C, or phosphoinositides turnover. Expl Cell Res. 177: 414-427
20. Zhang H., Buckley N. E., Gibson K. and Spiegel S. (1990) Sphingosine stimulates cellular proliferation via a protein kinase C-independent pathway. J. Biol. Chem. 265: 76-81
21. Mattie M., Brooker G. and Spiegel S. (1994) Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphate-independent pathway. J. Biol. Chem. 269: 3181-3188
22. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65: 55-63
23. Obeid L. M., Linardic C. M., Karolak L. A. and Hannun Y. A. (1993) Programmed cell death induced by ceramide. Science 259: 1769-1771
24. Iwata M., Herrington J. and Zager R. A. (1995) Sphingosine: a mediator of acute renal tubular injury and subsequent cytoresistance. Proc. Natl. Acad. Sci. USA 92: 8970-8974
25. Hannun Y. A. (1994) The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 269: 3125-3128
26. Ebert M., Yokoyama M., Friess H., Kobrin M. S., Buchler M. W. and Korc M. (1995) Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int. J. Cancer 62: 529-53